Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cartesian Therapeutics (RNAC) Tax Rate (2021 - 2022)

Cartesian Therapeutics (RNAC) has disclosed Tax Rate for 2 consecutive years, with 5.14% as the latest value for Q4 2022.

  • Quarterly Tax Rate fell 625.0% to 5.14% in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 73.75% through Dec 2022, down 64968.0% year-over-year, with the annual reading at 6.59% for FY2025, 698.0% up from the prior year.
  • Tax Rate for Q4 2022 was 5.14% at Cartesian Therapeutics, down from 3.91% in the prior quarter.
  • The five-year high for Tax Rate was 3.91% in Q3 2022, with the low at 766.12% in Q3 2021.